The second report showed that in colon cancer patients, high ERK5 expression is associated with poor prognosis, and that constitutive activation of MEK5–ERK5 promotes proliferation of HCT116 and SSW620 colon cancer cells [47]. The gene discussed is MAP2K5; the disease is malignant colon neoplasm.